(Q28316487)

English

Pharmacological basis for antihypertensive effects of intravenous labetalol

scientific article published on January 1, 1977

In more languages

Statements

scholarly article

0 references

Pharmacological basis for antihypertensive effects of intravenous labetalol (English)

0 references

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

10.1136/HRT.39.1.99

https://api.crossref.org/works/10.1136/HRT.39.1.99

15 March 2022

author name string

D. A. Richards

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12778

15 March 2022

B. N. Prichard

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12778

15 March 2022

A. J. Boakes

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12778

15 March 2022

J. Tuckman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12778

15 March 2022

E. J. Knight

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12778

15 March 2022

language of work or name

0 references

publication date

January 1977

0 references

full work available at URL

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12778/pdf/?tool=EBI

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12778

15 March 2022

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12778/?tool=EBI

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12778

15 March 2022

https://europepmc.org/articles/PMC483200

online access status

content deliverer

Europe PubMed Central

0 references

https://europepmc.org/articles/PMC483200?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12778

15 March 2022

https://syndication.highwire.org/content/doi/10.1136/hrt.39.1.99

1 reference

10.1136/HRT.39.1.99

https://api.crossref.org/works/10.1136/HRT.39.1.99

15 March 2022

British Heart Journal

0 references

39

0 references

1

0 references

99-106

0 references

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483200

20 March 2017

Haemodynamic effects of long-term oral labetalol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483200

20 March 2017

Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483200

20 March 2017

Letter: Intravenous labetalol in severe hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483200

29 September 2017

Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483200

29 September 2017

beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483200

2 June 2018

Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483200

2 June 2018

A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS

1 reference

https://pubmed.ncbi.nlm.nih.gov/12778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical science and molecular medicine

8

48

975

Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine and diazoxide: the use of AH 5158 in the treatment of hypertension (English)

author name string

Prichard, B.N.C.; Thompson, F.O.; Boakes, A.J.; Joekes, A.M.

publication date

1975

1 reference

10.1136/HRT.39.1.99

https://api.crossref.org/works/10.1136/HRT.39.1.99

15 March 2022

Identifiers

10.1136/HRT.39.1.99

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28316487&oldid=1745688222"